zoledronic acid has been researched along with Cells, Neoplasm Circulating in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, ZT; Gao, DM; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Wang, L; Wang, WQ; Wu, WZ; Xu, HX; Zhang, JB; Zhang, W; Zhu, XD; Zhuang, PY | 1 |
| Andreis, D; Bertoni, R; Bonelli, M; Bottini, A; Brugnoli, G; Cappelletti, M; Ferrero, G; Foroni, C; Fox, SB; Fumarola, C; Generali, D; Maldotti, M; Milan, M; Parissenti, A; Petronini, PG; Pritzker, K; Pritzker, L; Santini, D; Strina, C; Takano, E; Venturini, S; Zanoni, V | 1 |
| Antón, A; Arizcuma, A; Barnadas, A; Calvo, L; Chacón, JI; Codes, M; Crespo, C; de Juan, A; de la Piedra, C; Gavilá, J; Gómez, P; Heras, L; Luque, M; Mahillo-Fernández, I; Manso, L; Margelí, M; Martin-Fernández, M; Martinez, P; Meseguer, C; Murias, A; Perelló, A; Pérez, D; Ruiz-Borrego, M; Salvador, J; Seguí, MÁ; Tusquets, I; Zamora, P | 1 |
| Blackwell, K; Harnden, K | 1 |
| Aft, R; Ali, A; Chavez-MacGregor, M; Diemer, K; Dietz, J; Eberlein, T; Ellis, M; Fracasso, PM; Gillanders, W; Herrmann, V; Kuo, S; Ma, C; Mortimer, J; Naughton, M; Pluard, T; Shannon, W; Taylor, M; Trinkaus, K; Watson, M; Weilbaecher, K; Weiss, P; Ylagan, L; Zhai, J; Zoberi, I | 1 |
| Becker, S; Fehm, T; Gebauer, G; Hirnle, P; Huober, J; Janni, W; Krämer, B; Lück, HJ; Solomayer, EF; Wackwitz, B; Wallwiener, D | 1 |
| Iguchi, H | 1 |
2 review(s) available for zoledronic acid and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Routine use of zoledronic acid in early-stage breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Diphosphonates; Disease-Free Survival; Female; Humans; Imidazoles; Neoplastic Cells, Circulating; Randomized Controlled Trials as Topic; Zoledronic Acid | 2015 |
[Molecular mechanism and potential targets for bone metastasis].
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Male; Mice; Mice, Nude; Neoplastic Cells, Circulating; Osteolysis; Parathyroid Hormone-Related Protein; Prostatic Neoplasms; RANK Ligand; Zoledronic Acid | 2007 |
3 trial(s) available for zoledronic acid and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Immunohistochemistry; Middle Aged; Neoplastic Cells, Circulating; Zoledronic Acid | 2014 |
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Zoledronic Acid | 2010 |
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Arthralgia; Bone Marrow Cells; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Treatment Outcome; Zoledronic Acid | 2012 |
2 other study(ies) available for zoledronic acid and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dendritic Cells; Diphosphonates; Heterografts; Humans; Imidazoles; Immunosuppression Therapy; Indoles; Interleukin-12 Subunit p40; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Zoledronic Acid | 2013 |
Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study).
Topics: Biomarkers; Bone Neoplasms; Bone Remodeling; Breast Neoplasms; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Kaplan-Meier Estimate; Middle Aged; Neoplastic Cells, Circulating; Proportional Hazards Models; Treatment Outcome; Zoledronic Acid | 2014 |